22 drugs to watch in 2012

The Street's Adam Feuerstein has compiled a list of 22 drugs with PDUFA dates between December and July. Highlights include Vivus ($VVUS), Arena Pharmaceuticals ($ARNA) and Orexigen Therapeutics ($OREX) taking another shot at winning approval for their three obesity drugs, and FDA rulings on two inhaled drugs from Alexza Pharmaceuticals ($ALXA) and MAP Pharmaceuticals ($MAPP). Calendar

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.